Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for MRZM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
September 30, 2024 36.80M
June 30, 2024 30.91M
March 31, 2024 32.40M
December 31, 2023 28.72M
September 30, 2023 58.87M
June 30, 2023 29.71M
March 31, 2023 23.04M
December 31, 2022 21.27M
September 30, 2022 22.78M
June 30, 2022 22.95M
March 31, 2022 19.76M
December 31, 2021
September 30, 2021 13.26M
June 30, 2021 12.45M
March 31, 2021 1.727M
December 31, 2020 1.796M
September 30, 2020 0.4661M
June 30, 2020 0.4416M
March 31, 2020 0.3955M
December 31, 2019 0.2702M
September 30, 2019 0.0726M
June 30, 2019 0.2127M
March 31, 2019 0.0954M
December 31, 2018
September 30, 2018 0.0802M
Date Value
June 30, 2018 0.0234M
March 31, 2018 0.663M
December 31, 2017
September 30, 2017 0.2546M
June 30, 2017 0.2316M
March 31, 2017 0.2519M
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013 20.64M
September 30, 2013 16.87M
June 30, 2013 17.67M
March 31, 2013
December 31, 2012 22.27M
September 30, 2012 22.43M
June 30, 2012 22.34M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Athersys, Inc. --
RenovaCare, Inc. --
Mera Pharmaceuticals, Inc. --
PhaseRx, Inc. --
Aditxt, Inc. 49.08M